Kenneth B. Gordon

25.5k citations
206 papers · 16.7k indexed · 12 hit papers · h-index 61

Impact in

  • Dermatology top 0.01%
    • Dermatology and Skin Diseases
  • Immunology top 0.05%
    • Psoriasis: Treatment and Pathogenesis

Papers in

Kenneth B. Gordon

196 papers receiving 16.1k citations

Hit Papers

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial 2022 · 173 citations
17320072026201320194008001.2k

Peers

Kenneth B. Gordon
Comparison fields: 5 of 137
  • Dermatology 7.7k
  • Immunology 13.8k
  • Rheumatology 3.3k
  • Hematology 2.0k
  • Complementary and Manual Therapy 347
Replace Richard G. Langley with:
Richard G. Langley Canada
Craig L. Leonardi United States
Alan Menter United States
Wolf‐­Henning Boehncke Germany
Bruce Strober United States
Kristian Reich Germany
Diamant Thaçi Germany
Neil J. Korman United States
Paolo Gisondi Italy
Gerald G. Krueger United States
Kenneth B. Gordon relative to Richard G. Langley Canada Richard G. Langley's profile →
Citations per field
00.5×1.5×
Richard G. Langley · 1×
Citations per year

Countries citing papers authored by Kenneth B. Gordon

Since Specialization
Citations

This map shows the geographic impact of Kenneth B. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth B. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth B. Gordon more than expected).

Fields of papers citing papers by Kenneth B. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth B. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth B. Gordon. The network helps show where Kenneth B. Gordon may publish in the future.

Co-authors

The 25 scholars most cited alongside Kenneth B. Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenneth B. Gordon Line = papers co-authored together Kenneth B. Gordon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20243
3 202427
4 20245
5 20240
6 20235
7 202314
8 20232
9 202323
10 202220
11 202169
12 202112
13 202014
14
Efficacy and Safety of a Potent and Highly Selective Oral Tyrosine Kinase 2 Inhibitor, BMS-986165, in Patients with Moderate-to-Severe Plaque Psoriasis: A Phase II, Randomized, Placebo-Controlled Trial
20181
15
EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS
201810
16 20171
17 201165
18
Remittive effects of intramuscular alefacept in psoriasis.
200354
19
Repeated courses of IM alefacept in psoriasis Rationale and design of an international study that mimics the clinical practice setting
20037
20 20015

About Kenneth B. Gordon

Kenneth B. Gordon is a scholar working on Dermatology, Immunology, Hematology, Pathology and Forensic Medicine and Rheumatology, having authored 206 papers that have together received 16.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (173 papers), Dermatology and Skin Diseases (89 papers), Asthma and respiratory diseases (36 papers), Autoimmune Bullous Skin Diseases (34 papers), Autoimmune and Inflammatory Disorders Research (28 papers), Health Systems, Economic Evaluations, Quality of Life (24 papers), Pharmaceutical studies and practices (21 papers) and Cytokine Signaling Pathways and Interactions (13 papers). The work is most often cited by research in Dermatology (7.7k citations), Immunology (13.8k citations), Rheumatology (3.3k citations), Hematology (2.0k citations) and Complementary and Manual Therapy (347 citations). Kenneth B. Gordon has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Craig L. Leonardi, Kim Papp, Alan Menter, Alice B. Gottlieb, Mark Lebwohl, Richard G. Langley, Alexa B. Kimball, Neil J. Korman, Steven R. Feldman and Kristian Reich. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology, Seminars in Cutaneous Medicine and Surgery, British Journal of Dermatology and Journal of Dermatological Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026